Primary Immunodeficiencies: Genotype-Phenotype Correlations

Immunogenomics and Human Disease

Volumn , Issue , 2006, Pages 443-460

  Vihinen, Mauno ^a   Durandy, Anne ^b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

ADA deficiency; Autosomal recessive (AR); Central nervous system dysfunctions; Covariant residues; Gene diversification; Genotype phenotype correlations; Human immunodeficiency virus (HIV); Phagocytosis; Signal dependent membrane targetting

Indexed keywords

EID: 33750968008     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470034092.ch20     Document Type: Chapter

References (51)

1. Abdul-Manan N, Aghazadeh B, Liu GA, Majumdar A, Ouerfelli O, Siminovitch KA, Rosen MK. 1999. Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein. Nature 399: 379-383.
2. Arredondo-Vega FX, Santisteban I, Daniels S, Toutain S, Hershfield MS. 1998. Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles. Am J Hum Genet 63: 1049-1059.
3. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, Morecki S, Andolfi G, Tabucchi A, Carlucci F, Marinello E, Cattaneo F, Vai S, Servida P, Miniero R, Roncarolo MG, Bordignon C. 2002. Science 2410-2413.
4. Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J. 1998. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet 62: 1034-1043.
5. Conley ME, Notarangelo LD, Etzioni A. 1999. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: 190-197.
6. Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M. 2000. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96: 2317-2322.
7. Derry JM, Ochs HD, Francke U. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78: 635-644.
8. EllmeierW, Jung S, Sunshine MJ, Hatam F, Xu Y, Baltimore D, Mano H, Littman DR. 2000. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J Exp Med 192: 1611-1624.
9. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, Kurimoto M, Niida Y, Matsuoka H, Sakiyama Y, Iwata T, Tsuchiya S, Tatsuzawa O, Yoshizaki K, Kishimoto T. 1998. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91: 595-602.
10. Hansson H, Mattsson PT, Allard P, Haapaniemi P, Vihinen M, Smith CI, Hard T. 1998. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37: 2912-2924.
11. Hershfield MS. 2003. Genotype is an important determinant of phenotype in adenosine deaminase deficiency. Curr Opin Immunol 15: 571-577.
12. Imai K, Nonoyama S, Ochs HD. 2003. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol 3: 427-436.
13. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S. 2004. Clinical course of patients with WASP gene mutations. Blood 103: 456-464.
14. Imai K, Zhu Y, Revy P, Morio T, Mizutani S, Fischer A, Nonoyama S, Durandy A. 2005. Analysis of class switch recombination and somatic hypermutations in patients affected with autosomal dominant hyper-IgM type 2. Clin Immunol 115: 277-285.
15. Hyvönen M, Saraste M. 1997. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia. EMBO J 16: 3396-2304.
16. Johnston J, Kelley RI, Feigenbaum A, Cox GF, Iyer GS, Funanage VL, Proujansky R. 1997. Am J Hum Genet 61(5): 1053-1058.
17. Lindvall JM, Blomberg KE, Valiaho J, Vargas L, Heinonen JE, Berglof A, Mohamed AJ, Nore BF, Vihinen M, Smith CI. 2005. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol Rev 203: 200-215.
18. Mao C, Zhou M, Uckun FM. 2001. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia. J Biol Chem 276: 41435-41443.
19. Moshous D, Callebaut I, de Chasseval R, Corneo B, Cavazzana-Calvo M, Le Deist F, Tezcan I, Sanal O, Bertrand Y, Philippe N, Fischer A, de Villartay JP. 2001. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105: 177-186.
20. Notarangelo LD, Ochs HD. 2003. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Curr Opin Immunol 15: 585-591.
21. Ochs HD. 1998. The Wiskott-Aldrich syndrome. Semin Hematol 35: 332-345.
22. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA, Concannon P. 2001. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8: 1175-1185.
23. Ollila J, Lappalainen I, Vihinen M. 1996. Sequence specificity in CpG mutation hotspots. FEBS Lett 396: 119-122.
24. Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalcin I, Davies G, Tezcan I, Ersoy F, Catalan N, Imai K, Fischer A, Durandy A. 2004. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 110: 22-29.
25. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
26. Riikonen P, Vihinen M. 1999. MUTbase: maintenance and analysis of distributed mutation databases. Bioinformatics 15: 852-859.
27. Rong SB, Vihinen M. 2000. Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain. J Mol Med 78: 530-537.
28. Samarghitean C, Valiaho J, Vihinen M. 2004. Online registry of genetic and clinical immunodeficiency diagnostic laboratories, IDdiagnostics. J Clin Immunol 24: 53-61.
29. Schwarz K, Gauss GH, Ludwig L, Pannicke U, Li Z, Lindner D, Friedrich W, Seger RA, Hansen-Hagge TE, Desiderio S, Lieber MR, Bartram CR. 1996. RAG mutations in human B cell-negative SCID. Science 274: 97-99.
30. Shen B, Vihinen M. 2003. RankViaContact: ranking and visualization of amino acid contacts. Bioinformatics 19: 2161-2162.
31. Shen B, Vihinen M. 2004. Conservation and covariance in PH domain sequences: physicochemical profile and information theoretical analysis of XLA-causing mutations in the Btk PH domain. Protein Eng Des Select 17: 267-276.
32. Ta VT, Nagaoka H, Catalan N, Durandy A, Fischer A, Imai K, Nonoyama S, Tashiro J, Ikegawa M, Ito S, Kinoshita K, Muramatsu M, Honjo T. 2003. AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat Immunol 4(9): 843-848.
33. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME,Witte ON. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72: 279-290.
34. Väliaho J, Riikonen P, Vihinen M. 2000. Novel immunodeficiency data servers. Immunol Rev 178: 177-185.
35. Väliaho J, Pusa M, Ylinen T, Vihinen M. 2002. IDR: the ImmunoDeficiency Resource. Nucl Acids Res 30: 232-234.
36. Väliaho J, Samarghitean C, Piirilä H, Pusa M, Vihinen M. 2005a. Primary Immunodeficiency Diseases, Ochs HD, Smith CIE, Puck JM (eds).
37. Väliaho J, Riikonen P, Vihinen M. 2005b. Biomedical data description with XML. Distribution of immunodeficiency fact files-from Web to WAP. BMC Med Inform Dec Making, 5: 21.
38. Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tosi M. 1996. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genet 59: 308-319.
39. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361: 226-233.
40. Vihinen M, Nilsson L, Smith CIE. 1994a. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Biochem Biophys Res Commun 205: 1270-1277.
41. Vihinen M, Vetrie D, Maniar HS, Ochs HD, Zhu Q, Vorechovský I, Webster ADA, Notarangelo LD, Nilsson L, Sowadski JM, Smith CIE. 1994b. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. Proc Natl Acad Sci USA 91: 12803-12807.
42. Vihinen M, Cooper MD, de Saint Basile G, Fischer A, Good RA, Hendriks RW, Kinnon C, Kwan S-P, Litman GW, Notarangelo LD, Ochs HD, Rosen FS, Vetrie D, Webster ADB, Zegers BJM, Smith CIE. 1995a. BTKbase: a database of XLA-causing mutations. International Study Group. Immunol Today 16: 460-465.
43. Vihinen M, Zvelebil MJ, Zhu Q, Brooimans RA, Ochs HD, Zegers BJ, Nilsson L, Waterfield MD, Smith CI. 1995b. Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia. Biochemistry 34: 1475-1481.
44. Vihinen M, Belohradsky BH, Haire RN, Holinski-Feder E, Kwan S-P, Lappalainen I, Lehväslaiho H, Lester T, Meindl A, Ochs HD, Ollila J, Vorechovský I, Weiss M, Smith CIE. 1997. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucl Acids Res 25: 166-171.
45. Vihinen M, Kwan SP, Lester T, Ochs HD, Resnick I, Valiaho J, Conley ME, Smith CI. 1999. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat 13: 280-285.
46. Vihinen M, Arredondo-Vega FX, Casanova JL, Etzioni A, Giliani S, Hammarstrom L, Hershfield MS, Heyworth PG, Hsu AP, Lahdesmaki A, Lappalainen I, Notarangelo LD, Puck JM, Reith W, Roos D, Schumacher RF, Schwarz K, Vezzoni P, Villa A, Valiaho J, Smith CI. 2001. Primary immunodeficiency mutation databases. Adv Genet 43: 103-188.
47. Villa A, Santagata S, Bozzi F, Giliani S, Frattini A, Imberti L, Gatta LB, Ochs HD, Schwarz K, Notarangelo LD, Vezzoni P, Spanopoulou E. 1998. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93: 885-896.
48. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, Arkwright PD, Baniyash M, Brooks EG, Conley ME, Cortes P, Duse M, Fasth A, Filipovich AM, Infante AJ, Jones A, Mazzolari E, Muller SM, Pasic S, Rechavi G, Sacco MG, Santagata S, Schroeder ML, Seger R, Strina D, Ugazio A, Valiaho J, Vihinen M, Vogler LB, Ochs H, Vezzoni P, FriedrichW, Schwarz K. 2001. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 97: 81-88.
49. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA. 2002. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111: 565-576.
50. Wilson DK, Rudolph FB, Quiocho FA. 1991. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 252: 1278-1284.
51. Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hageman T, Saffran DC, Kwan S-P, Nilsson L, Smith CIE, Witte ON, Chen S-H, Ochs HD. 1994. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). J Exp Med 180: 461-470.